Inspire Medical announced upcoming presentations and events highlighting its neurostimulator therapy for obstructive sleep apnea at the International Surgical Sleep Society and American Academy of Otolaryngology meetings.
The data adds to the volume of independent evidence establishing precision oral devices as a leading treatment option for OSA, according to the company.
Apnimed will present new research on drug candidates AD109 and AD113, targeting obstructive sleep apnea, at the European Respiratory Society’s International Congress 2023.
Updated clinical trial data indicate that the First Line Obstructive Sleep Apnea Treatment study, comparing precision oral appliance therapy and CPAP, is on track to achieve all endpoints, according to Prosomnus.
The partnership will help Side Health meet the growing demand to detect and treat undiagnosed sleep apnea among its patients.
Lifesaving equipment is being denied payment because of rigid criteria in local coverage determinations and existing coverage provided by CMS is not reflective of rapidly evolving technology in the field.
Sleep deprivation alone in mice caused only mild cognitive impairment, so what causes the selective degeneration of neurons that characteristically die in dementia?
The companies detail how the new partnership, which combines Sunrise's artificial intelligence solutions and the technologies of eXciteOSA, will improve patient care.